Showing results (1571-1580 of 6,509) with videos related to

Sort By:
Pageof 651
Cancer Immunology, Immunotherapy : CII|April 10, 2026
Targeting the COX-2/PGE2 axis to enhance NK and T cell immunotherapy in brain tumorsChih-Jie Shen, Joy Florentino-Krasnov, You-Cheng Liao, et al.
Cancer Immunology, Immunotherapy : CII|May 2, 2026
Dual-modality imaging enables longitudinal biodistribution profiling of intracerebroventricular CAR-T therapy in orthotopic gliomaChunzhao Li, Peng Zhang, Xiaobin Zhao, et al.
Cancer Immunology, Immunotherapy : CII|March 26, 2026
Clinical characteristics, prognostic factors, and feasibility of ICI continuation in immune checkpoint inhibitor-related pneumonitisKeisuke Masumoto, Kazuya Tsubouchi, Ryosuke Matsukane, et al.
Cancer Immunology, Immunotherapy : CII|May 27, 2026
Flow-cytometric profiling of large extracellular vesicles as immunophenotypic biomarkers in head and neck squamous cell carcinomaJudith Büntzel, Markus Maulhardt, Alexander Casimir Angleitner, et al.
Cancer Immunology, Immunotherapy : CII|June 2, 2026
Integrated immunophenotypic and ProMisE molecular profiling as predictors of immune checkpoint inhibitor response in recurrent endometrial cancerKomei Katayama, Nobuhisa Yoshikawa, Wenting Liu, et al.
Cancer Immunology, Immunotherapy : CII|June 5, 2026
Explainable AI reveals squamous histology and U-shaped PD-L1 patterns as primary subgroup predictors of neoadjuvant and perioperative immunotherapy benefit in NSCLC: a machine learning analysisFangfang Shen, Zheqing Zhu, Junge Liu, et al.
Cancer Immunology, Immunotherapy : CII|June 14, 2026
Real-world outcomes of ipilimumab plus nivolumab in esophageal squamous cell carcinoma: a multi-institutional large cohort studyShuichiro Hara, Tomoki Makino, Shigeto Nakai, et al.
Cancer Immunology, Immunotherapy : CII|July 19, 2023
Successful ex vivo expansion of tumor infiltrating lymphocytes with systemic chemotherapy prior to surgical resectionJulien Balzeau, Anindita Ravindran, Xin Wang, et al.
Cancer Immunology, Immunotherapy : CII|June 27, 2023
Using patient-derived tumor organoids from common epithelial cancers to analyze personalized T-cell responses to neoantigensAnup Y Parikh, Robert Masi, Billel Gasmi, et al.
Cancer Immunology, Immunotherapy : CII|June 10, 2023
Unbiased chemokine receptor screening reveals similar efficacy of lymph node- and tumor-targeted T cell immunotherapyLudwig O Pachmayr, Anton Muehlbauer, Sophie Flommersfeld, et al.
Pageof 651